Cargando…

Statistical analysis of two arm randomized pre-post designs with one post-treatment measurement

BACKGROUND: Randomized pre-post designs, with outcomes measured at baseline and after treatment, have been commonly used to compare the clinical effectiveness of two competing treatments. There are vast, but often conflicting, amount of information in current literature about the best analytic metho...

Descripción completa

Detalles Bibliográficos
Autor principal: Wan, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305561/
https://www.ncbi.nlm.nih.gov/pubmed/34303343
http://dx.doi.org/10.1186/s12874-021-01323-9
_version_ 1783727603294666752
author Wan, Fei
author_facet Wan, Fei
author_sort Wan, Fei
collection PubMed
description BACKGROUND: Randomized pre-post designs, with outcomes measured at baseline and after treatment, have been commonly used to compare the clinical effectiveness of two competing treatments. There are vast, but often conflicting, amount of information in current literature about the best analytic methods for pre-post designs. It is challenging for applied researchers to make an informed choice. METHODS: We discuss six methods commonly used in literature: one way analysis of variance (“ANOVA”), analysis of covariance main effect and interaction models on the post-treatment score (“ANCOVAI” and “ANCOVAII”), ANOVA on the change score between the baseline and post-treatment scores (“ANOVA-Change”), repeated measures (“RM”) and constrained repeated measures (“cRM”) models on the baseline and post-treatment scores as joint outcomes. We review a number of study endpoints in randomized pre-post designs and identify the mean difference in the post-treatment score as the common treatment effect that all six methods target. We delineate the underlying differences and connections between these competing methods in homogeneous and heterogeneous study populations. RESULTS: ANCOVA and cRM outperform other alternative methods because their treatment effect estimators have the smallest variances. cRM has comparable performance to ANCOVAI in the homogeneous scenario and to ANCOVAII in the heterogeneous scenario. In spite of that, ANCOVA has several advantages over cRM: i) the baseline score is adjusted as covariate because it is not an outcome by definition; ii) it is very convenient to incorporate other baseline variables and easy to handle complex heteroscedasticity patterns in a linear regression framework. CONCLUSIONS: ANCOVA is a simple and the most efficient approach for analyzing pre-post randomized designs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-021-01323-9.
format Online
Article
Text
id pubmed-8305561
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83055612021-07-28 Statistical analysis of two arm randomized pre-post designs with one post-treatment measurement Wan, Fei BMC Med Res Methodol Research BACKGROUND: Randomized pre-post designs, with outcomes measured at baseline and after treatment, have been commonly used to compare the clinical effectiveness of two competing treatments. There are vast, but often conflicting, amount of information in current literature about the best analytic methods for pre-post designs. It is challenging for applied researchers to make an informed choice. METHODS: We discuss six methods commonly used in literature: one way analysis of variance (“ANOVA”), analysis of covariance main effect and interaction models on the post-treatment score (“ANCOVAI” and “ANCOVAII”), ANOVA on the change score between the baseline and post-treatment scores (“ANOVA-Change”), repeated measures (“RM”) and constrained repeated measures (“cRM”) models on the baseline and post-treatment scores as joint outcomes. We review a number of study endpoints in randomized pre-post designs and identify the mean difference in the post-treatment score as the common treatment effect that all six methods target. We delineate the underlying differences and connections between these competing methods in homogeneous and heterogeneous study populations. RESULTS: ANCOVA and cRM outperform other alternative methods because their treatment effect estimators have the smallest variances. cRM has comparable performance to ANCOVAI in the homogeneous scenario and to ANCOVAII in the heterogeneous scenario. In spite of that, ANCOVA has several advantages over cRM: i) the baseline score is adjusted as covariate because it is not an outcome by definition; ii) it is very convenient to incorporate other baseline variables and easy to handle complex heteroscedasticity patterns in a linear regression framework. CONCLUSIONS: ANCOVA is a simple and the most efficient approach for analyzing pre-post randomized designs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-021-01323-9. BioMed Central 2021-07-24 /pmc/articles/PMC8305561/ /pubmed/34303343 http://dx.doi.org/10.1186/s12874-021-01323-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wan, Fei
Statistical analysis of two arm randomized pre-post designs with one post-treatment measurement
title Statistical analysis of two arm randomized pre-post designs with one post-treatment measurement
title_full Statistical analysis of two arm randomized pre-post designs with one post-treatment measurement
title_fullStr Statistical analysis of two arm randomized pre-post designs with one post-treatment measurement
title_full_unstemmed Statistical analysis of two arm randomized pre-post designs with one post-treatment measurement
title_short Statistical analysis of two arm randomized pre-post designs with one post-treatment measurement
title_sort statistical analysis of two arm randomized pre-post designs with one post-treatment measurement
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305561/
https://www.ncbi.nlm.nih.gov/pubmed/34303343
http://dx.doi.org/10.1186/s12874-021-01323-9
work_keys_str_mv AT wanfei statisticalanalysisoftwoarmrandomizedprepostdesignswithoneposttreatmentmeasurement